This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Farmitalia Carlo Erba. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: **Roberto Maj: Innovator in Ergoline Esters**
Introduction
Roberto Maj, an accomplished inventor based in Saronno, Italy, has made significant contributions to the field of pharmaceutical chemistry. With a keen focus on developing innovative compounds, his work continues to influence the landscape of drug development.
Latest Patents
Roberto Maj holds one notable patent related to Ergoline esters. This invention features a specific formula wherein R1 can be either hydrogen or a methyl group, R2 is a C1-C4 hydrocarbon, R3 might be hydrogen or methoxy, R4 can be hydrogen or a halogen, and R5 is a C1-C4 alkyl. The active compounds derived from this patent demonstrate efficacy at the central nervous system level, marking a significant advancement in pharmaceutical sciences. The patent also outlines a process for the preparation of these compounds and their pharmaceutically acceptable salts.
Career Highlights
Roberto's professional journey has been marked by his role at Farmitalia Carlo Erba S.p.A., a company renowned for its innovations in the pharmaceutical industry. His expertise and dedication to developing effective therapeutics have positioned him as a key player in his field.
Collaborations
Throughout his career, Roberto has worked alongside esteemed colleagues such as Aldemio Temperilli and Sergio Mantegani. Their collaboration has fostered a productive environment for research and innovation, enabling them to push the boundaries of pharmaceutical science.
Conclusion
Roberto Maj's contributions, particularly through his patent on Ergoline esters, highlight the importance of innovation in addressing medical challenges. His work not only underscores his skills as an inventor but also illustrates the collaborative spirit that drives advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile